Tirzepatide Excites in Obesity Now Too, Says Lilly
The once-weekly investigational twincretin drug is in phase 3 development for obesity and under regulatory review, with a decision expected soon for type 2 diabetes.
Stay updated with breaking news from Compete With. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The once-weekly investigational twincretin drug is in phase 3 development for obesity and under regulatory review, with a decision expected soon for type 2 diabetes.
The NATO foreign ministers’ meeting on 6-7 April witnessed, for the first time, the participation of Australia, Japan, New Zealand and South Korea. Secretary... 07.04.2022, Sputnik International
Greg Ippolito Talks About Helping Small Brands Compete with Large Organizations
Greg Ippolito Talks About Helping Small Brands Compete with Large Organizations
Greg Ippolito Talks About Helping Small Brands Compete with Large Organizations